In 2003, we carried out a field survey in order to investigate the significance of sub-clinical tickborne bacterial infections in African dogs from the Ivory Coast (n = 137) and Gabon (n = 255). So far, only limited data on this topic are available in Africa when compared with the USA and Europe, and in most of the cases, serological techniques have been applied [1] . In this study, we used PCR amplification and DNA sequencing to screen different tick-borne bacterial pathogens in the blood of dogs.
The dogs from the Ivory Coast were resident in the capital Abidjan and were used for surveillance purposes by protection companies. They were kept in 16 different kennels and received regular medical prophylaxis including vaccinations and external anti-parasitic treatments. Dogs from Gabon were recruited in 15 small villages in the area of Ogooué-Ivindo, situated in the northeastern part of the country. They were nonkennelled companion animals and received no specific medical prevention. All the dogs appeared healthy at the time of the examination. All Gabonese dogs were infested by fleas and some of them by Haemaphysalis leachi ticks, while no ectoparasites were found in dogs from the Ivory Coast. Blood was collected in EDTA-anticoagulated tubes kept deep-frozen at )20°C until further processing.
In the laboratory, DNA extraction was carried out using QIAamp DNA Mini Kits (Qiagen Ltd, Crawley, UK) according to the manufacturer's recommendations. Briefly, blood samples were digested for 10 min with a mixture of proteinase K and detergents at 56°C to liberate host and pathogen DNA. DNA was extracted from 200 lL of blood and purified DNA was eluted in 100 lL of low ionic strength buffer, pH 8.0. DNA from individual dogs was screened by PCR, using specific primers, for the presence of Ehrlichia and Anaplasma species (Ivory Coast), and Ehrlichia and Anaplasma species, Mycoplasma spp. and Rickettsia spp. (Gabon). PCR assays amplified a 350 base pair fragment of the 16S rRNA gene for Ehrlichia ⁄ Anaplasma species (primer sequences: ggtaccyacagaagaagtcc and tagcactcatcgtttacagc), 16S rRNA gene for Mycoplasma spp. (primer sequences: atacggcccatattcctacg and tgctccaccacttgttca) and ompB gene for Rickettsia spp. (primer sequences: gacaattaatatcggtgacgg and tgcatcagcattaccgcttgc). Sequencing was required to further characterise positive results for Ehrlichia ⁄ Anaplasma PCR and limited sequencing was performed for Mycoplasma spp.
Overall, 10 ⁄ 392 (2.6%) of the tested dogs were positive for E. canis and 5 ⁄ 392 (1.3%) for A. platys ( Table 1 ). The majority of them was from the Ivory Coast; 10 were positive for E. canis and two for A. platys. In Gabon, only three dogs were positive for A. platys and none was positive for E. canis. In this latter country, a high proportion of dogs (114 ⁄ 255, 44.7%) was positive for Mycoplasma spp. Sequencing of 10 Mycoplasma positive samples revealed four Mycoplasma haemocanis, one Mycoplasma haemofelis, and five samples of a novel Mycoplasma. No sample was positive for Rickettsia spp. The three Gabonese dogs positive for A. platys were co-infected with Mycoplasma spp. No E. canis and A. platys co-infections were present in the Ivory Coast dogs.
Ehrlichia canis is responsible for canine monocytic ehrlichiosis, a widespread infectious disease in the distribution area of its vector Rhipicephalus sanguineus, the brown dog tick. Interestingly, in a previous seroprevalence survey of E. canis infection in the same population of dogs [1] , 67.8% of dogs in the Ivory Coast were positive and only 3.1% in Gabon, while our molecular study found 7.3% and 0%, respectively. Moreover, the average titres of positive samples from the Ivory Coast dogs were much higher than those from the Gabonese dogs. The absence of E. canis DNA among 255 dogs in Gabon is consistent with the low prevalence of its vector, R. sanguineus.
Rhipicephalus sanguineus is also considered as being the main vector of A. platys, the cause of canine infectious cyclic thrombocytopenia, although naturally infected dogs do not necessarily exhibit clinical signs [2] . Anaplasma platys has already been isolated from a dog in the Democratic Republic of the Congo [2] . The presence of A. platys in the Gabon dog population despite the apparently low exposure to Rhipicephalus ticks requires further investigation. However, our study suggests that specific testing for A. platys is recommended when a clinical suspicion of E. canis infection is not confirmed.
Mycoplasma haemocanis is responsible for anaemia in dogs but clinical signs mainly appear in those that are immuno-compromised or splenectomised [3, 4] . The prevalence of Mycoplasma infection in the Gabonese dogs of this study is high and this may be explained by persistent infection, which has been previously reported in dogs [4] . Transmission by R. sanguineus is suspected [3] but this does not correlate with the high prevalence of Mycoplasma infection in an environment of low R. sanguineus exposure. The dogs sampled in Gabon were parasited by fleas and Haemaphysalis leachi ticks, and the role of these arthropods in the transmission of Mycoplasma spp. should be further investigated. The finding of novel haemoplasma species, including one with high similarity to M. haemofelis, in this dog population, requires further investigation in light of the new canine haemoplasma species being recognised elsewhere [5] . The high level of Mycoplasma infection in Gabon could be responsible for an increased morbidity and mortality, when combined with stress or in the case of co-infection with other arthropod-transmitted infections. In our study, the three dogs positive for A. platys were also infected by Mycoplasma spp.
Overall, the high prevalence of sub-clinical canine tick-borne bacterial infections from these two African countries indicates the circulation of these agents, more particularly Mycoplasma spp.; however, the transmission biology may differ from those described previously.
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